|
Market Closed -
NYSE
01:30:02 19/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.030 USD | -6.36% |
|
-12.71% | -70.82% |
| 14/08 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 14/08 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ADCT Stock
- Consensus ADC Therapeutics SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
